6VTW image
Deposition Date 2020-02-13
Release Date 2020-04-15
Last Version Date 2024-10-30
Entry Detail
PDB ID:
6VTW
Keywords:
Title:
De novo protein design enables the precise induction of RSV-neutralizing antibodies
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
2.60 Å
R-Value Free:
0.28
R-Value Work:
0.20
R-Value Observed:
0.21
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:S4_2.45
Chain IDs:A
Chain Length:47
Number of Molecules:1
Biological Source:Human respiratory syncytial virus A2
Polymer Type:polypeptide(L)
Molecule:101F Fab Heavy Chain
Chain IDs:C (auth: H)
Chain Length:219
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Molecule:101F Fab Light Chain
Chain IDs:B (auth: L)
Chain Length:219
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation

Abstact

De novo protein design has been successful in expanding the natural protein repertoire. However, most de novo proteins lack biological function, presenting a major methodological challenge. In vaccinology, the induction of precise antibody responses remains a cornerstone for next-generation vaccines. Here, we present a protein design algorithm called TopoBuilder, with which we engineered epitope-focused immunogens displaying complex structural motifs. In both mice and nonhuman primates, cocktails of three de novo-designed immunogens induced robust neutralizing responses against the respiratory syncytial virus. Furthermore, the immunogens refocused preexisting antibody responses toward defined neutralization epitopes. Overall, our design approach opens the possibility of targeting specific epitopes for the development of vaccines and therapeutic antibodies and, more generally, will be applicable to the design of de novo proteins displaying complex functional motifs.

Legend

Protein

Chemical

Disease

Primary Citation of related structures